| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.741 | 0.003 | 0.753 | Anesthetic general | 0.728 0.003 DBMET01567 0.662 0.004 DBMET00109 0.386 0.018 DBMET00110 0.753 0.003 DBMET01214 0.661 0.004 DBMET01216 | DBMET01214 | |
| 0.614 | 0.006 | 0.614 | Anticonvulsant | 0.517 0.011 DBMET01567 0.18 0.099 DBMET00109 0.48 0.014 DBMET01214 0.305 0.039 DBMET01216 | ||
| 0.514 | 0.004 | 0.571 | Lipocortins synthesis antagonist | 0.505 0.004 DBMET01567 0.401 0.009 DBMET00109 0.385 0.01 DBMET00110 0.571 0.002 DBMET01214 0.477 0.004 DBMET01216 0.313 0.019 DBMET01215 | DBMET01214 | |
| 0.488 | 0.012 | 0.489 | Psychostimulant | 0.438 0.017 DBMET01567 0.185 0.089 DBMET00109 0.32 0.038 DBMET00110 0.489 0.012 DBMET01214 0.457 0.015 DBMET01216 0.24 0.062 DBMET01215 | DBMET01214 | |
| 0.372 | 0.021 | 0.46 | Cyclic AMP phosphodiesterase inhibitor | 0.409 0.015 DBMET01567 0.254 0.062 DBMET00109 0.189 0.103 DBMET00110 0.46 0.009 DBMET01214 0.43 0.013 DBMET01216 | DBMET01214 | |
| 0.342 | 0.005 | 0.342 | 5 Hydroxytryptamine 7 antagonist | 0.177 0.015 DBMET01567 0.25 0.008 DBMET01214 0.207 0.012 DBMET01216 | ||
| 0.353 | 0.052 | 0.425 | Spasmolytic | 0.343 0.055 DBMET01567 0.17 0.145 DBMET00109 0.317 0.064 DBMET00110 0.319 0.063 DBMET01214 0.425 0.035 DBMET01216 | DBMET01216 | |
| 0.343 | 0.056 | 0.493 | Aldehyde oxidase inhibitor | 0.493 0.034 DBMET01567 0.2 0.105 DBMET00109 0.447 0.04 DBMET01214 0.427 0.043 DBMET01216 | DBMET01567 | |
| 0.309 | 0.04 | 0.309 | 5 Hydroxytryptamine uptake stimulant | 0.2 0.152 DBMET01567 0.202 0.147 DBMET00110 0.225 0.11 DBMET01214 0.214 0.126 DBMET01216 | ||
| 0.323 | 0.059 | 0.342 | Interleukin 2 agonist | 0.342 0.049 DBMET01567 0.313 0.065 DBMET00109 0.314 0.064 DBMET01214 0.276 0.092 DBMET01216 0.336 0.052 DBMET01215 | DBMET01567 | |
| 0.324 | 0.077 | 0.599 | Cholesterol antagonist | 0.599 0.019 DBMET01567 0.544 0.026 DBMET00109 0.25 0.125 DBMET00110 0.386 0.052 DBMET01214 0.497 0.033 DBMET01216 | DBMET01567 | |
| 0.271 | 0.039 | 0.467 | RNA-directed DNA polymerase inhibitor | 0.338 0.025 DBMET01567 0.272 0.039 DBMET00109 0.257 0.046 DBMET00110 0.332 0.026 DBMET01214 0.467 0.013 DBMET01216 | DBMET01216 | |
| 0.315 | 0.106 | 0.518 | Immunosuppressant | 0.458 0.045 DBMET01567 0.403 0.061 DBMET00109 0.518 0.028 DBMET00110 0.367 0.078 DBMET01214 0.364 0.079 DBMET01216 0.205 0.192 DBMET01215 | DBMET00110 | |
| 0.241 | 0.033 | 0.286 | Tumour necrosis factor antagonist | 0.233 0.036 DBMET01567 0.146 0.106 DBMET00109 0.286 0.021 DBMET01214 0.239 0.034 DBMET01216 | DBMET01214 | |
| 0.251 | 0.066 | 0.366 | DNA synthesis inhibitor | 0.305 0.042 DBMET01567 0.307 0.041 DBMET00109 0.366 0.027 DBMET00110 0.238 0.075 DBMET01214 0.341 0.032 DBMET01216 | DBMET00110 | |
| 0.201 | 0.019 | 0.243 | Nav1.1 sodium channel blocker | 0.178 0.024 DBMET01567 0.174 0.025 DBMET01214 0.243 0.013 DBMET01216 | DBMET01216 | |
| 0.337 | 0.156 | 0.516 | Caspase 9 stimulant | 0.344 0.15 DBMET01567 0.277 0.221 DBMET00109 0.401 0.11 DBMET01214 0.516 0.054 DBMET01216 | DBMET01216 | |
| 0.252 | 0.099 | 0.32 | Hypoxia-inducible factor 1 alpha inhibitor | 0.26 0.091 DBMET01567 0.223 0.125 DBMET00109 0.2 0.151 DBMET00110 0.32 0.057 DBMET01214 0.313 0.06 DBMET01216 | DBMET01214 | |
| 0.267 | 0.115 | 0.489 | Transcription factor NF kappa B inhibitor | 0.378 0.069 DBMET01567 0.261 0.119 DBMET00109 0.354 0.075 DBMET00110 0.295 0.097 DBMET01214 0.489 0.046 DBMET01216 0.349 0.077 DBMET01215 | DBMET01216 | |
| 0.242 | 0.099 | 0.547 | Immunostimulant | 0.345 0.066 DBMET01567 0.215 0.112 DBMET00109 0.208 0.115 DBMET01214 0.341 0.067 DBMET01216 0.547 0.023 DBMET01215 | DBMET01215 | |
| 0.275 | 0.134 | 0.275 | GABA C receptor rho-3 antagonist | 0.254 0.151 DBMET01214 | ||
| 0.228 | 0.087 | 0.332 | Tumour necrosis factor alpha release inhibitor | 0.332 0.043 DBMET01567 0.246 0.077 DBMET00109 0.197 0.112 DBMET00110 0.261 0.07 DBMET01214 0.192 0.116 DBMET01216 | DBMET01567 | |
| 0.233 | 0.093 | 0.233 | 5 Hydroxytryptamine 1E antagonist | 0.189 0.143 DBMET01214 | ||
| 0.152 | 0.017 | 0.179 | Anabolic | 0.179 0.007 DBMET01567 0.172 0.009 DBMET00109 0.098 0.066 DBMET00110 0.164 0.012 DBMET01214 0.158 0.014 DBMET01216 0.096 0.069 DBMET01215 | DBMET01567 | |
| 0.14 | 0.008 | 0.16 | Phosphodiesterase 4C inhibitor | 0.14 0.008 DBMET01567 0.066 0.029 DBMET00109 0.16 0.006 DBMET01214 0.151 0.007 DBMET01216 | DBMET01214 | |
| 0.226 | 0.098 | 0.226 | Interleukin agonist | 0.182 0.137 DBMET01567 | ||
| 0.209 | 0.09 | 0.371 | Angiogenesis stimulant | 0.371 0.027 DBMET01567 0.28 0.057 DBMET00109 0.278 0.058 DBMET01214 0.312 0.045 DBMET01216 0.369 0.028 DBMET01215 | DBMET01567 | |
| 0.176 | 0.057 | 0.314 | Diuretic | 0.159 0.07 DBMET01567 0.309 0.021 DBMET00110 0.314 0.02 DBMET01214 0.123 0.102 DBMET01216 0.131 0.094 DBMET01215 | DBMET01214 | |
| 0.143 | 0.034 | 0.311 | Bronchodilator | 0.201 0.018 DBMET01567 0.128 0.04 DBMET00109 0.114 0.049 DBMET00110 0.179 0.022 DBMET01214 0.311 0.009 DBMET01216 | DBMET01216 | |
| 0.123 | 0.017 | 0.151 | Glycine receptor antagonist | 0.139 0.01 DBMET01567 0.101 0.031 DBMET00109 0.112 0.023 DBMET00110 0.112 0.023 DBMET01214 0.151 0.007 DBMET01216 | DBMET01216 | |
| 0.17 | 0.064 | 0.242 | Interleukin 6 antagonist | 0.152 0.087 DBMET01567 0.233 0.027 DBMET00110 0.142 0.102 DBMET01214 0.242 0.025 DBMET01216 | DBMET01216 | |
| 0.188 | 0.083 | 0.301 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.276 0.032 DBMET01567 0.301 0.023 DBMET00109 0.224 0.056 DBMET00110 0.286 0.028 DBMET01214 0.25 0.043 DBMET01216 | DBMET00109 | |
| 0.122 | 0.022 | 0.122 | Interleukin 5 antagonist | 0.109 0.032 DBMET01567 0.112 0.03 DBMET01214 0.082 0.069 DBMET01216 | ||
| 0.111 | 0.011 | 0.184 | Androgen agonist | 0.184 0.005 DBMET01567 0.173 0.006 DBMET00109 0.06 0.041 DBMET00110 0.141 0.008 DBMET01214 0.098 0.015 DBMET01216 | DBMET01567 | |
| 0.234 | 0.141 | 0.278 | Vasodilator, peripheral | 0.234 0.14 DBMET01567 0.206 0.169 DBMET01214 0.278 0.109 DBMET01216 | DBMET01216 | |
| 0.142 | 0.051 | 0.31 | Adenylate cyclase inhibitor | 0.245 0.019 DBMET01567 0.145 0.048 DBMET00109 0.201 0.025 DBMET01214 0.31 0.012 DBMET01216 | DBMET01216 | |
| 0.137 | 0.047 | 0.137 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.102 | 0.02 | 0.135 | Glycine receptor agonist | 0.122 0.012 DBMET01567 0.097 0.023 DBMET00109 0.073 0.048 DBMET00110 0.068 0.06 DBMET01214 0.135 0.009 DBMET01216 | DBMET01216 | |
| 0.111 | 0.032 | 0.131 | Phosphodiesterase 4D inhibitor | 0.124 0.027 DBMET01567 0.131 0.024 DBMET01214 0.127 0.025 DBMET01216 | DBMET01214 | |
| 0.11 | 0.034 | 0.11 | Acetylcholine nicotinic antagonist | 0.076 0.059 DBMET01214 | ||
| 0.295 | 0.22 | 0.295 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.139 | 0.065 | 0.139 | Nav1.2 sodium channel blocker | 0.11 0.096 DBMET01567 0.106 0.102 DBMET01214 0.125 0.077 DBMET01216 | ||
| 0.134 | 0.062 | 0.134 | Cholinergic antagonist | |||
| 0.119 | 0.049 | 0.119 | Acetylcholine release stimulant | 0.102 0.084 DBMET01214 | ||
| 0.129 | 0.059 | 0.129 | Acetylcholine muscarinic antagonist | 0.1 0.091 DBMET01216 | ||
| 0.207 | 0.139 | 0.233 | Gastrin inhibitor | 0.231 0.104 DBMET01567 0.2 0.148 DBMET00109 0.206 0.14 DBMET01214 0.215 0.126 DBMET01216 0.233 0.101 DBMET01215 | DBMET01215 | |
| 0.111 | 0.045 | 0.111 | DNA directed RNA polymerase inhibitor | 0.085 0.077 DBMET01214 0.086 0.076 DBMET01216 | ||
| 0.129 | 0.063 | 0.129 | Acetylcholine antagonist | |||
| 0.119 | 0.054 | 0.119 | Ferrochelatase inhibitor | |||
| 0.074 | 0.018 | 0.091 | Lipocortins synthesis agonist | 0.079 0.014 DBMET01567 0.08 0.014 DBMET00109 0.059 0.038 DBMET00110 0.091 0.008 DBMET01214 0.062 0.033 DBMET01216 | DBMET01214 | |
| 0.101 | 0.051 | 0.101 | Phosphodiesterase 6D inhibitor | 0.098 0.056 DBMET01567 0.094 0.065 DBMET01214 0.092 0.071 DBMET01216 | ||
| 0.13 | 0.081 | 0.13 | Nav1.6 sodium channel blocker | |||
| 0.131 | 0.083 | 0.133 | Lipid peroxidase inhibitor | 0.112 0.103 DBMET01567 0.133 0.081 DBMET01214 | DBMET01214 | |
| 0.086 | 0.038 | 0.086 | HIV-1 reverse transcriptase inhibitor | |||
| 0.058 | 0.012 | 0.111 | Glucocorticoid antagonist | 0.062 0.011 DBMET01567 0.044 0.017 DBMET00109 0.03 0.024 DBMET00110 0.111 0.004 DBMET01214 0.03 0.024 DBMET01216 | DBMET01214 | |
| 0.1 | 0.057 | 0.1 | Electrolyte absorption antagonist | |||
| 0.113 | 0.071 | 0.16 | Interleukin 8 antagonist | 0.108 0.079 DBMET01567 0.16 0.028 DBMET01214 | DBMET01214 | |
| 0.138 | 0.096 | 0.171 | Interferon gamma antagonist | 0.155 0.071 DBMET01567 0.141 0.091 DBMET00109 0.171 0.056 DBMET01214 0.156 0.071 DBMET01216 | DBMET01214 | |
| 0.093 | 0.052 | 0.147 | Androgen antagonist | 0.147 0.023 DBMET01567 0.136 0.026 DBMET00109 0.139 0.026 DBMET01214 0.079 0.066 DBMET01216 | DBMET01567 | |
| 0.101 | 0.06 | 0.145 | UDP-glucose 4-epimerase inhibitor | 0.139 0.033 DBMET01567 0.092 0.07 DBMET00109 0.086 0.079 DBMET00110 0.12 0.044 DBMET01214 0.145 0.031 DBMET01216 | DBMET01216 | |
| 0.054 | 0.014 | 0.054 | Phosphodiesterase 6C inhibitor | 0.048 0.028 DBMET01567 0.045 0.038 DBMET00109 0.045 0.037 DBMET00110 0.053 0.016 DBMET01214 0.048 0.028 DBMET01216 | ||
| 0.113 | 0.074 | 0.148 | DNA polymerase I inhibitor | 0.148 0.05 DBMET01567 0.132 0.06 DBMET00109 0.112 0.075 DBMET01214 0.135 0.058 DBMET01216 | DBMET01567 | |
| 0.049 | 0.014 | 0.098 | RNA-directed RNA polymerase stimulant | 0.067 0.01 DBMET01567 0.07 0.009 DBMET00109 0.098 0.006 DBMET01214 0.041 0.016 DBMET01216 | DBMET01214 | |
| 0.049 | 0.015 | 0.049 | Kainate receptor agonist | 0.044 0.023 DBMET01567 0.049 0.015 DBMET01216 | ||
| 0.131 | 0.1 | 0.19 | Adenylate cyclase stimulant | 0.177 0.028 DBMET01567 0.161 0.047 DBMET00109 0.123 0.117 DBMET00110 0.128 0.107 DBMET01214 0.19 0.019 DBMET01216 | DBMET01216 | |
| 0.05 | 0.019 | 0.074 | 5-Alpha-reductase inhibitor | 0.058 0.016 DBMET01567 0.037 0.026 DBMET00109 0.074 0.013 DBMET01214 | DBMET01214 | |
| 0.035 | 0.008 | 0.035 | DNA polymerase III inhibitor | 0.031 0.014 DBMET01567 0.031 0.014 DBMET00110 0.033 0.011 DBMET01214 0.031 0.013 DBMET01216 | ||
| 0.123 | 0.098 | 0.123 | Farnesoid X receptor antagonist | 0.12 0.105 DBMET01214 | ||
| 0.132 | 0.109 | 0.135 | Heat shock protein 70 antagonist | 0.133 0.107 DBMET01567 0.135 0.094 DBMET00110 0.132 0.113 DBMET01214 0.135 0.097 DBMET01216 | DBMET01216 | |
| 0.037 | 0.014 | 0.037 | Phosphodiesterase 6B inhibitor | 0.032 0.018 DBMET01214 0.028 0.025 DBMET01216 | ||
| 0.06 | 0.04 | 0.06 | Phosphodiesterase 1A inhibitor | |||
| 0.046 | 0.026 | 0.046 | Guanylate cyclase stimulant | 0.041 0.036 DBMET01216 | ||
| 0.031 | 0.011 | 0.031 | Thymidine phosphorylase inhibitor | 0.025 0.02 DBMET01567 0.027 0.016 DBMET01216 | ||
| 0.131 | 0.111 | 0.197 | Arachidonic acid antagonist | 0.177 0.057 DBMET01567 0.179 0.054 DBMET00109 0.177 0.057 DBMET00110 0.197 0.036 DBMET01214 0.154 0.084 DBMET01216 | DBMET01214 | |
| 0.043 | 0.025 | 0.069 | Thymidine kinase inhibitor | 0.06 0.014 DBMET01567 0.056 0.015 DBMET00109 0.065 0.012 DBMET00110 0.043 0.025 DBMET01214 0.069 0.011 DBMET01216 | DBMET01216 | |
| 0.057 | 0.039 | 0.077 | Pregnane X receptor antagonist | 0.053 0.051 DBMET01567 0.077 0.008 DBMET01214 | DBMET01214 | |
| 0.03 | 0.013 | 0.03 | Nicotinic acid receptor 2 antagonist | |||
| 0.026 | 0.011 | 0.026 | Phosphodiesterase 6G inhibitor | 0.024 0.015 DBMET01214 | ||
| 0.026 | 0.011 | 0.026 | Phosphodiesterase 6H inhibitor | 0.024 0.015 DBMET01214 | ||
| 0.086 | 0.071 | 0.086 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.028 | 0.013 | 0.028 | Acid ceramidase inhibitor | |||
| 0.035 | 0.021 | 0.035 | Purinergic P2Y2 antagonist | 0.034 0.023 DBMET01567 0.034 0.023 DBMET01214 0.034 0.023 DBMET01216 | ||
| 0.092 | 0.082 | 0.175 | AMP-activated protein kinase stimulant | 0.175 0.016 DBMET01567 0.1 0.07 DBMET00109 0.094 0.078 DBMET01214 0.108 0.06 DBMET01216 | DBMET01567 | |
| 0.023 | 0.014 | 0.03 | Estrone sulfatase inhibitor | 0.03 0.01 DBMET01214 | DBMET01214 | |
| 0.02 | 0.011 | 0.058 | 5-Alpha-reductase 1 inhibitor | 0.058 0.007 DBMET01214 | DBMET01214 | |
| 0.053 | 0.044 | 0.053 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.026 | 0.019 | 0.037 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 DBMET01567 0.026 0.02 DBMET00109 0.025 0.024 DBMET01214 0.037 0.006 DBMET01216 | DBMET01216 | |
| 0.027 | 0.02 | 0.04 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.034 0.014 DBMET00109 0.04 0.011 DBMET01214 0.027 0.02 DBMET01216 | DBMET01214 | |
| 0.165 | 0.159 | 0.165 | 5 Hydroxytryptamine release stimulant | |||
| 0.122 | 0.115 | 0.122 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.164 | 0.158 | 0.4 | Cardiotonic | 0.288 0.061 DBMET01567 0.194 0.125 DBMET00109 0.237 0.091 DBMET00110 0.169 0.153 DBMET01214 0.4 0.029 DBMET01216 | DBMET01216 | |
| 0.068 | 0.062 | 0.109 | Na+ K+ transporting ATPase inhibitor | 0.101 0.031 DBMET01567 0.097 0.034 DBMET00109 0.094 0.037 DBMET00110 0.078 0.052 DBMET01214 0.109 0.024 DBMET01216 | DBMET01216 | |
| 0.036 | 0.031 | 0.041 | Glucose-6-phosphate dehydrogenase inhibitor | 0.04 0.022 DBMET01567 0.038 0.026 DBMET00109 0.041 0.02 DBMET01214 0.036 0.03 DBMET01216 | DBMET01214 | |
| 0.117 | 0.113 | 0.117 | Acetylcholine M1 receptor antagonist | |||
| 0.019 | 0.014 | 0.05 | 5-Alpha-reductase 2 inhibitor | 0.031 0.009 DBMET01567 0.017 0.016 DBMET00109 0.05 0.007 DBMET01214 | DBMET01214 | |
| 0.013 | 0.01 | 0.013 | DNA polymerase III polC-type inhibitor | |||
| 0.062 | 0.059 | 0.062 | Alpha 1b adrenoreceptor antagonist | |||
| 0.016 | 0.014 | 0.046 | Progesterone agonist | 0.024 0.009 DBMET01567 0.02 0.011 DBMET00109 0.046 0.005 DBMET01214 | DBMET01214 | |
| 0.022 | 0.02 | 0.022 | Phosphodiesterase 6A inhibitor | |||
| 0.081 | 0.079 | 0.081 | Prolactin inhibitor | |||
| 0.019 | 0.018 | 0.029 | Corticosteroid-like | 0.021 0.014 DBMET01567 0.022 0.014 DBMET00109 0.029 0.007 DBMET01214 | DBMET01214 | |
| 0.099 | 0.098 | 0.099 | Nav1.3 sodium channel blocker | |||
| 0.036 | 0.035 | 0.036 | Nicotinic acid receptor 1 agonist | |||
| 0.039 | 0.044 | 0.093 | Adenylate cyclase 1 inhibitor | 0.071 0.012 DBMET01567 0.053 0.023 DBMET00109 0.093 0.005 DBMET01216 | DBMET01216 | |
| 0.105 | 0.113 | 0.198 | Protein kinase stimulant | 0.111 0.103 DBMET01214 0.198 0.042 DBMET01216 | DBMET01216 | |
| 0.197 | 0.206 | 0.245 | Histamine release inhibitor | 0.224 0.177 DBMET01567 0.245 0.159 DBMET01214 0.203 0.198 DBMET01216 | DBMET01214 | |
| 0.007 | 0.017 | 0.019 | Glucocorticoid agonist | 0.012 0.01 DBMET01567 0.019 0.008 DBMET01214 | DBMET01214 | |
| 0.039 | 0.051 | 0.071 | Aldosterone antagonist | 0.05 0.029 DBMET00110 0.071 0.014 DBMET01214 | DBMET01214 | |
| 0.053 | 0.065 | 0.076 | Ryanodine receptor antagonist | 0.057 0.049 DBMET01214 0.076 0.011 DBMET01216 | DBMET01216 | |
| 0.041 | 0.057 | 0.07 | Aromatase inhibitor | 0.056 0.044 DBMET01567 0.07 0.034 DBMET01214 | DBMET01214 | |
| 0.009 | 0.025 | 0.016 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.01 DBMET00110 0.016 0.004 DBMET01214 | DBMET01214 | |
| 0.053 | 0.073 | 0.061 | Heme oxygenase stimulant | 0.061 0.043 DBMET01214 | DBMET01214 | |
| 0.044 | 0.064 | 0.053 | Biliverdin reductase inhibitor | 0.053 0.049 DBMET01567 0.052 0.051 DBMET01216 | DBMET01567 | |
| 0.034 | 0.057 | 0.068 | Phosphodiesterase 4A inhibitor | 0.045 0.039 DBMET01567 0.052 0.034 DBMET01214 0.068 0.025 DBMET01216 | DBMET01216 | |
| 0.013 | 0.037 | 0.021 | Progesterone receptor B antagonist | 0.021 0.011 DBMET01214 | DBMET01214 | |
| 0.155 | 0.179 | 0.178 | Superoxide dismutase inhibitor | 0.167 0.159 DBMET01214 0.178 0.144 DBMET01215 | DBMET01215 | |
| 0.079 | 0.104 | 0.093 | Bile acid receptor antagonist | 0.093 0.066 DBMET01567 0.093 0.065 DBMET00109 0.087 0.081 DBMET01214 | DBMET00109 | |
| 0.081 | 0.107 | 0.093 | Anesthetic local | 0.093 0.089 DBMET01216 | DBMET01216 | |
| 0.1 | 0.129 | 0.115 | DNA repair enzyme inhibitor | 0.113 0.088 DBMET01567 0.111 0.092 DBMET01214 0.115 0.084 DBMET01216 | DBMET01216 | |
| 0.015 | 0.045 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.017 DBMET01567 0.021 0.013 DBMET01216 | DBMET01216 | |
| 0.124 | 0.157 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.132 0.107 DBMET01567 0.132 0.109 DBMET00109 0.141 0.069 DBMET00110 0.15 0.043 DBMET01216 | DBMET01216 | |
| 0.043 | 0.077 | 0.083 | Matrix metalloproteinase inhibitor | 0.083 0.035 DBMET01215 | DBMET01215 | |
| 0.059 | 0.093 | 0.075 | Keratolytic | 0.075 0.057 DBMET01214 | DBMET01214 | |
| 0.027 | 0.061 | 0.038 | Membrane dipeptidase inhibitor | 0.038 0.029 DBMET01215 | DBMET01215 | |
| 0.036 | 0.071 | 0.044 | Parathyroid hormone antagonist | 0.044 0.035 DBMET01216 | DBMET01216 | |
| 0.018 | 0.053 | 0.054 | Progesterone antagonist | 0.03 0.029 DBMET01567 0.054 0.017 DBMET01214 | DBMET01214 | |
| 0.071 | 0.108 | 0.079 | Estrogen-related receptor beta agonist | 0.079 0.069 DBMET01567 | DBMET01567 | |
| 0.05 | 0.087 | 0.059 | Interferon inducer | 0.059 0.056 DBMET01216 | DBMET01216 | |
| 0.1 | 0.137 | 0.16 | Cell wall synthesis inhibitor | 0.16 0.056 DBMET01567 0.113 0.11 DBMET01216 | DBMET01567 | |
| 0.131 | 0.169 | 0.146 | Neurotrophic factor enhancer | 0.146 0.144 DBMET00110 | DBMET00110 | |
| 0.08 | 0.119 | 0.1 | Alkylator | 0.1 0.088 DBMET01214 | DBMET01214 | |
| 0.01 | 0.052 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.016 0.008 DBMET01214 | DBMET01214 | |
| 0.021 | 0.063 | 0.028 | Hedgehog signaling activator | 0.027 0.019 DBMET01567 0.028 0.018 DBMET00109 | DBMET00109 | |
| 0.066 | 0.115 | 0.088 | NADH dehydrogenase inhibitor | 0.083 0.068 DBMET01567 0.088 0.059 DBMET01216 | DBMET01216 | |
| 0.072 | 0.122 | 0.115 | Cystathionine beta-synthase inhibitor | 0.106 0.071 DBMET00109 0.115 0.062 DBMET00110 0.092 0.086 DBMET01214 | DBMET00110 | |
| 0.029 | 0.083 | 0.089 | Mineralocorticoid receptor antagonist | 0.043 0.042 DBMET00110 0.089 0.009 DBMET01214 | DBMET01214 | |
| 0.107 | 0.161 | 0.297 | Nitric oxide antagonist | 0.155 0.09 DBMET01567 0.159 0.088 DBMET00109 0.245 0.053 DBMET00110 0.297 0.041 DBMET01216 | DBMET01216 | |
| 0.11 | 0.166 | 0.164 | Pregnane X receptor agonist | 0.145 0.063 DBMET01214 0.164 0.033 DBMET01216 | DBMET01216 | |
| 0.032 | 0.087 | 0.058 | Argininosuccinate synthase inhibitor | 0.058 0.038 DBMET01216 | DBMET01216 | |
| 0.077 | 0.138 | 0.133 | Microtubule formation inhibitor | 0.126 0.055 DBMET01567 0.133 0.048 DBMET00109 0.106 0.081 DBMET00110 0.116 0.066 DBMET01216 | DBMET00109 | |
| 0.1 | 0.162 | 0.206 | NOS3 expression enhancer | 0.139 0.084 DBMET01567 0.13 0.098 DBMET00109 0.206 0.039 DBMET01214 | DBMET01214 | |
| 0.049 | 0.114 | 0.08 | Metalloproteinase-2 inhibitor | 0.08 0.052 DBMET01215 | DBMET01215 | |
| 0.202 | 0.27 | 0.24 | Calcium channel L-type activator | 0.24 0.217 DBMET01214 | DBMET01214 | |
| 0.023 | 0.097 | 0.059 | Liver X receptor agonist | 0.059 0.017 DBMET01216 | DBMET01216 | |
| 0.155 | 0.233 | 0.221 | Vasodilator, coronary | 0.221 0.163 DBMET01567 0.208 0.175 DBMET00109 | DBMET01567 | |
| 0.102 | 0.184 | 0.172 | MAP kinase kinase 2 inhibitor | 0.172 0.102 DBMET01214 | DBMET01214 | |
| 0.058 | 0.14 | 0.123 | Expectorant | 0.11 0.059 DBMET01567 0.123 0.049 DBMET01216 0.115 0.055 DBMET01215 | DBMET01216 | |
| 0.141 | 0.223 | 0.325 | Peptidyltransferase inhibitor | 0.325 0.017 DBMET01567 0.302 0.024 DBMET00109 0.276 0.035 DBMET01216 0.266 0.04 DBMET01215 | DBMET01567 | |
| 0.072 | 0.159 | 0.127 | Alpha-N-acetylglucosaminidase inhibitor | 0.11 0.088 DBMET01567 0.127 0.071 DBMET01216 | DBMET01216 | |
| 0.158 | 0.253 | 0.403 | Sodium/bile acid cotransporter inhibitor | 0.315 0.066 DBMET01567 0.298 0.081 DBMET00109 0.318 0.064 DBMET01214 0.323 0.06 DBMET01216 0.403 0.016 DBMET01215 | DBMET01215 | |
| 0.092 | 0.188 | 0.28 | Growth hormone agonist | 0.159 0.08 DBMET01567 0.136 0.1 DBMET00109 0.254 0.042 DBMET01216 0.28 0.036 DBMET01215 | DBMET01215 | |
| 0.064 | 0.161 | 0.119 | GABA C receptor antagonist | 0.119 0.054 DBMET00110 | DBMET00110 | |
| 0.05 | 0.149 | 0.165 | Antineoplastic alkaloid | 0.16 0.025 DBMET00110 0.165 0.023 DBMET01216 | DBMET01216 | |
| 0.064 | 0.164 | 0.131 | Mucolytic | 0.113 0.062 DBMET01567 0.11 0.064 DBMET01216 0.131 0.045 DBMET01215 | DBMET01215 | |
| 0.096 | 0.202 | 0.21 | Hepatoprotectant | 0.135 0.126 DBMET01567 0.182 0.078 DBMET01216 0.21 0.059 DBMET01215 | DBMET01215 | |
| 0.026 | 0.134 | 0.062 | Carbamoyl phosphate synthetase inhibitor | 0.062 0.041 DBMET01216 | DBMET01216 | |
| 0.02 | 0.137 | 0.036 | Tubulin agonist | 0.032 0.029 DBMET00109 0.036 0.021 DBMET00110 0.036 0.021 DBMET01216 | DBMET01216 | |
| 0.025 | 0.146 | 0.111 | Antineoplastic antibiotic | 0.094 0.049 DBMET01567 0.088 0.052 DBMET00109 0.098 0.047 DBMET00110 0.111 0.041 DBMET01216 | DBMET01216 | |
| 0.109 | 0.23 | 0.275 | Vasodilator | 0.202 0.103 DBMET01216 0.275 0.057 DBMET01215 | DBMET01215 | |
| 0.063 | 0.183 | 0.13 | Toll-Like receptor 4 antagonist | 0.13 0.034 DBMET01216 | DBMET01216 | |
| 0.024 | 0.151 | 0.06 | Phosphofructokinase-1 inhibitor | 0.06 0.057 DBMET01216 | DBMET01216 | |
| 0.102 | 0.237 | 0.174 | ATPase inhibitor | 0.174 0.065 DBMET01216 | DBMET01216 | |
| 0.05 | 0.188 | 0.11 | Cholesterol synthesis inhibitor | 0.1 0.088 DBMET01567 0.11 0.075 DBMET00109 | DBMET00109 | |
| 0.058 | 0.197 | 0.114 | Hematopoietic | 0.114 0.025 DBMET01215 | DBMET01215 | |
| 0.022 | 0.164 | 0.051 | Alpha-mannosidase inhibitor | 0.051 0.041 DBMET01216 | DBMET01216 | |
| 0.013 | 0.156 | 0.048 | Toll-Like receptor 2 agonist | 0.048 0.024 DBMET01215 | DBMET01215 | |
| 0.009 | 0.156 | 0.052 | Estrogen agonist | 0.052 0.034 DBMET01216 | DBMET01216 | |
| 0.021 | 0.17 | 0.045 | Microtubule stabilization | 0.041 0.04 DBMET01567 0.045 0.034 DBMET01216 | DBMET01216 | |
| 0.024 | 0.174 | 0.067 | Phosphodiesterase III inhibitor | 0.067 0.045 DBMET01214 | DBMET01214 | |
| 0.035 | 0.187 | 0.068 | Adenine nucleotide translocase inhibitor | 0.068 0.017 DBMET01215 | DBMET01215 | |
| 0.125 | 0.295 | 0.245 | Antithrombotic | 0.197 0.181 DBMET01567 0.245 0.13 DBMET00110 0.209 0.166 DBMET01216 | DBMET00110 | |
| 0.067 | 0.242 | 0.131 | Factor V inhibitor | 0.131 0.029 DBMET01215 | DBMET01215 | |
| 0.078 | 0.284 | 0.13 | Antipruritic | 0.13 0.123 DBMET01214 | DBMET01214 | |
| 0.022 | 0.231 | 0.118 | Glutamate decarboxylase inhibitor | 0.118 0.021 DBMET01215 | DBMET01215 | |
| 0.026 | 0.247 | 0.103 | Analgesic, opioid | 0.103 0.03 DBMET01216 | DBMET01216 | |
| 0.122 | 0.349 | 0.238 | Apoptosis antagonist | 0.215 0.162 DBMET01567 0.238 0.139 DBMET01216 0.236 0.141 DBMET01215 | DBMET01216 | |
| 0.055 | 0.288 | 0.153 | Interleukin 4 antagonist | 0.153 0.047 DBMET01567 0.108 0.104 DBMET00109 | DBMET01567 | |
| 0.142 | 0.376 | 0.486 | Apoptosis agonist | 0.281 0.186 DBMET01567 0.482 0.08 DBMET00110 0.486 0.079 DBMET01216 | DBMET01216 | |
| 0.02 | 0.264 | 0.066 | Acetyl-CoA transferase 2 inhibitor | 0.066 0.022 DBMET00110 0.055 0.044 DBMET01216 | DBMET00110 | |
| 0.036 | 0.303 | 0.228 | Thrombolytic | 0.228 0.04 DBMET01215 | DBMET01215 | |
| 0.028 | 0.306 | 0.175 | Aminopeptidase B inhibitor | 0.175 0.028 DBMET01215 | DBMET01215 | |
| 0.02 | 0.304 | 0.071 | Sirtuin 1 inhibitor | 0.071 0.043 DBMET01215 | DBMET01215 | |
| 0.044 | 0.33 | 0.103 | Estrogen antagonist | 0.103 0.091 DBMET01214 | DBMET01214 | |
| 0.072 | 0.363 | 0.142 | Phospholipase C inhibitor | 0.142 0.123 DBMET01215 | DBMET01215 | |
| 0.015 | 0.317 | 0.068 | Histidine decarboxylase inhibitor | 0.068 0.053 DBMET01215 | DBMET01215 | |
| 0.047 | 0.356 | 0.083 | T cell inhibitor | 0.083 0.054 DBMET00110 | DBMET00110 | |
| 0.061 | 0.374 | 0.158 | Antioxidant | 0.158 0.155 DBMET01216 | DBMET01216 | |
| 0.03 | 0.353 | 0.114 | Opioid kappa receptor antagonist | 0.114 0.026 DBMET01216 | DBMET01216 | |
| 0.025 | 0.355 | 0.091 | ATPase (Vacuolar H+) inhibitor | 0.091 0.055 DBMET01567 | DBMET01567 | |
| 0.039 | 0.377 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.071 DBMET01215 | DBMET01215 | |
| 0.088 | 0.426 | 0.381 | Antibacterial | 0.221 0.206 DBMET00110 0.381 0.085 DBMET01216 0.244 0.182 DBMET01215 | DBMET01216 | |
| 0.01 | 0.349 | 0.068 | Opioid mu receptor antagonist | 0.068 0.047 DBMET01216 | DBMET01216 | |
| 0.054 | 0.402 | 0.122 | Interleukin 2 antagonist | 0.122 0.042 DBMET00110 | DBMET00110 | |
| 0.006 | 0.355 | 0.049 | Opioid mu receptor agonist | 0.049 0.029 DBMET01216 | DBMET01216 | |
| 0.004 | 0.366 | 0.114 | Kinesin antagonist | 0.114 0.006 DBMET01215 | DBMET01215 | |
| 0.004 | 0.366 | 0.114 | Kinesin-like protein 1 inhibitor | 0.114 0.006 DBMET01215 | DBMET01215 | |
| 0.043 | 0.406 | 0.153 | Histone deacetylase SIRT1 inhibitor | 0.153 0.059 DBMET01215 | DBMET01215 | |
| 0.005 | 0.371 | 0.088 | Opioid kappa receptor agonist | 0.088 0.011 DBMET01216 | DBMET01216 | |
| 0.115 | 0.489 | 0.436 | Antiinflammatory | 0.268 0.247 DBMET01567 0.436 0.118 DBMET01216 | DBMET01216 | |
| 0.076 | 0.452 | 0.148 | Catenin beta inhibitor | 0.148 0.11 DBMET01216 | DBMET01216 | |
| 0.003 | 0.381 | 0.021 | Prokineticin receptor 1 antagonist | 0.02 0.006 DBMET00109 0.021 0.006 DBMET00110 | DBMET00110 | |
| 0.01 | 0.418 | 0.056 | Angiotensin-converting enzyme inhibitor | 0.056 0.036 DBMET01215 | DBMET01215 | |
| 0.02 | 0.433 | 0.089 | Opioid antagonist | 0.089 0.057 DBMET01216 | DBMET01216 | |
| 0.006 | 0.423 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.012 DBMET01216 | DBMET01216 | |
| 0.033 | 0.464 | 0.399 | Interleukin antagonist | 0.399 0.031 DBMET01215 | DBMET01215 | |
| 0.081 | 0.529 | 0.275 | Cyclophilin D inhibitor | 0.275 0.186 DBMET01216 | DBMET01216 | |
| 0.005 | 0.454 | 0.049 | Opioid agonist | 0.049 0.041 DBMET01216 | DBMET01216 | |
| 0.02 | 0.474 | 0.128 | Glutathione S-transferase inhibitor | 0.128 0.019 DBMET01215 | DBMET01215 | |
| 0.017 | 0.472 | 0.105 | Protease inhibitor | 0.105 0.061 DBMET01215 | DBMET01215 | |
| 0.069 | 0.525 | 0.549 | Analgesic | 0.549 0.037 DBMET01216 | DBMET01216 | |
| 0.012 | 0.586 | 0.062 | Transcription factor AP-1 inhibitor | 0.062 0.041 DBMET01216 | DBMET01216 | |
| 0.047 | 0.681 | 0.272 | Caspase 3 stimulant | 0.272 0.095 DBMET01216 | DBMET01216 | |
| 0.007 | 0.671 | 0.036 | Erythropoietin receptor agonist | 0.036 0.032 DBMET01215 | DBMET01215 | |
| 0.01 | 0.698 | 0.204 | Anticoagulant | 0.204 0.052 DBMET01215 | DBMET01215 | |
| 0.009 | 0.751 | 0.103 | Chelator | 0.103 0.073 DBMET01215 | DBMET01215 | |
| 0.003 | 0.897 | 0.065 | Glucagon-like peptide 1 agonist | 0.065 0.045 DBMET01215 | DBMET01215 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |